Thursday, August 18, 2022 9:31:41 AM
<<<<<<< Wouldn’t their product be a predicate device making it easier to apply?>>>>>>>
In BIEL's 2019 RecoveryRx Clearance, K190251, for Post-Op Pain Relief both ActiBand (predesessor to the ActiPatch) and Sofpulse were used as Predicate Devices.
So, the FDA already has experience with a higher power wearable PEMF/PSWT device and accepted it as a Predicate for RecoveryRx.
https://www.accessdata.fda.gov/cdrh_docs/pdf19/K190251.pdf
Element79 Gold Corp Appoints Warren Levy to Board of Directors • ELMGF • Aug 28, 2024 9:51 AM
Integrated Ventures Announces Strategic Entry Into Health & Wellness Industry with Focus on GLP-1 Products • INTV • Aug 28, 2024 8:30 AM
ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • ELMGF • Aug 26, 2024 10:03 AM
North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM